Ran Mo
Affiliations: | China Pharmaceutical University |
Google:
"Ran Mo"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liu H, Liu M, Zhao Y, et al. (2023) Nanomedicine strategies to counteract cancer stemness and chemoresistance. Exploration of Targeted Anti-Tumor Therapy. 4: 630-656 |
| Shen S, Li T, Fan J, et al. (2022) Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor. Acta Pharmaceutica Sinica. B. 13: 1262-1273 |
| Wang Q, Chen C, Xu X, et al. (2022) APAF1-Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2201889 |
| Shen S, Lin S, Chen Y, et al. (2022) Combating Cancer Stem-Like Cell-Derived Resistance to Anticancer Protein by Liposome-Mediated Acclimatization Strategy. Nano Letters |
| Jiang T, Ma Y, Xu X, et al. (2021) Enzyme-instructed hybrid nanogel/nanofiber oligopeptide hydrogel for localized protein delivery. Acta Pharmaceutica Sinica. B. 11: 2070-2079 |
| Shen S, Xu X, Lin S, et al. (2021) A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells. Nature Nanotechnology. 16: 104-113 |
| Xu X, Huang X, Zhang Y, et al. (2020) Self-regulated hirudin delivery for anticoagulant therapy. Science Advances. 6 |
| Dong H, Xu X, Wang L, et al. (2020) Advances in living cell-based anticancer therapeutics. Biomaterials Science |
| Wang H, Xu X, Guan X, et al. (2020) Liposomal 9-Aminoacridine for Treatment of Ischemic Stroke: From Drug Discovery to Drug Delivery. Nano Letters |
| Xu X, Li T, Shen S, et al. (2019) Advances in Engineering Cells for Cancer Immunotherapy. Theranostics. 9: 7889-7905 |